Hospira Recalls Caloric Fluid Due to Mold Contamination

A recall has been issued by Hospira, Inc. for Lactated Ringers and 5% Dextrose, a caloric fluid used to restore electrolytes, due to the presence of mold, potentially causing life-threatening injuries. 

The Hospira recall was announced on January 25, after a customer reported finding spore-like material, consistent with mold, in the Lactated Ringers and 5% Dextrose Injection solution.  There have been no illnesses reported in connection to the recalled product.

The product is used as a source of water, electrolytes, calories, or as an alkalizing agent creating substantial risk to patients receiving the product intravenously. Possible health problems that could arise from the use of mold contaminated Lactated Ringers and Dextrose Injections include thrombosis, phlebitis, bacteremia, sepsis, septic shock, endocarditis, and may result in a fatal infection in a large range of patients.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The recalled product was packaged in 1,000 mL flexible containers with lot number 05-019-JT and an expiration date of May 1, 2013. The lot was distributed nationwide between June 2011 and January 2012 to wholesalers/distributors, hospitals and pharmacies.

Mold ingestion can cause serious adverse consequences that may be life threatening. In many cases mold ingestion symptoms will surface within 12-24 hours after exposure, causing abdominal cramps, persistent diarrhea, dehydration, nausea, or an overall upset stomach.

Intravenously ingested mold could also potentially lead to septicemia, which can progress to septic shock causing a sometimes fatal blood stream infection.

In October 2012, another Lactated Ringers and 5 Percent Dextrose Injection recall was issued by  Hospira Inc. after reports indicated that a leak between the cobra cap and fill-tube seal may have been contaminated with mold. Due to the overwrap of the container not being sterile, when the fluid leaked it became trapped between the container and overwrap causing air to flow freely, allowing for potential mold spore growth.

Anyone with the recalled solution in their inventory have been advised to stop use and distribution, immediately quarantine the product and call Stericycle at 1-888-965-5798 between the hours of 8am to 5pm EST Monday through Friday to arrange a return of the product. Hospira has announced there will be a replacement product from other lots available. For any medical inquiries please contact Hospira Medical Communications at 1-800-615-0187.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025
Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025 (Posted yesterday)

A series of four bellwether claims in the baby formula NEC lawsuit MDL will be ready to go before a federal juries in May 2025, August 2025, November 2025 and February 2026 according to a proposed trial schedule agreed upon by both plaintiffs and defendants.

AngioDynamics Port Catheter Lawsuit MDL Established in Southern District of California
AngioDynamics Port Catheter Lawsuit MDL Established in Southern District of California (Posted 2 days ago)

U.S. JPML has transferred all AngioDynamics port catheter lawsuits to the U.S. District Court for the Southern District of California, for coordinated discovery and pretrial proceedings as part of a federal MDL (multidistrict litigation).